Comprehensive Cell Solutions

Overview

Arising from New York Blood Center Enterprise’s mission to advance the life sciences, Comprehensive Cell Solutions (CCS) is a full-service CDMO offering process development, cell sourcing, cryopreservation, cGMP, and fill/finish for cell, gene, and regenerative therapies.

Decades of whole blood and apheresis collections have laid the foundation for excellence in cell procurement, enrichment, and expansion of key cell types, including stem cells derived from our cord blood bank, the largest in the world. CCS serves academic, preclinical, emerging biotech, and pharma clients, solving their unique manufacturing challenges with access to quality cellular starting material, R&D support, and technical expertise. Prior to planned expansion to Rye, NY in 2025, CCS maintains its headquarters with GTP and GMP facilities in Manhattan; the company has recently added commercial manufacturing sites in Houston, Texas and Louisville, Kentucky furthering its ability to provide a true “draw-to-thaw” solution for cell and gene therapies.